HN1999000029A - Combinaciones de estatina-inhibidor de mmp. - Google Patents
Combinaciones de estatina-inhibidor de mmp.Info
- Publication number
- HN1999000029A HN1999000029A HN1999000029A HN1999000029A HN1999000029A HN 1999000029 A HN1999000029 A HN 1999000029A HN 1999000029 A HN1999000029 A HN 1999000029A HN 1999000029 A HN1999000029 A HN 1999000029A HN 1999000029 A HN1999000029 A HN 1999000029A
- Authority
- HN
- Honduras
- Prior art keywords
- mmp inhibitor
- statin
- inhibitor combinations
- combination
- ldl
- Prior art date
Links
- 229940124761 MMP inhibitor Drugs 0.000 title abstract 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION SE REFIERE A UNA COMBINACION DE UN COMPUESTO DE ESTATINA, QUE SE SABE QUE CAUSA UNA REDUCCION EN LOS NIVELES PLASMATICOS DE COLESTEROL LIPOPROTEINAS DE BAJA DENSIDAD (LDL), Y UN INHIBIDOR DE MMP, QUE REDUCE LA RUPTURA DE TEJIDOS CONECTIVOS. LA COMBINACION ES UTIL PARA TRATAR TRASTORNOS VASCULARES Y PREVENIR LA INSUFICIENCIA CARDIACA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7826598P | 1998-03-17 | 1998-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN1999000029A true HN1999000029A (es) | 1999-09-29 |
Family
ID=22142950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN1999000029A HN1999000029A (es) | 1998-03-17 | 1999-03-16 | Combinaciones de estatina-inhibidor de mmp. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1063991A1 (es) |
| JP (1) | JP2002506818A (es) |
| KR (1) | KR20010041916A (es) |
| AR (1) | AR018113A1 (es) |
| AU (1) | AU1591699A (es) |
| BR (1) | BR9815745A (es) |
| CA (1) | CA2309588A1 (es) |
| CO (1) | CO5070670A1 (es) |
| GT (1) | GT199900039A (es) |
| HN (1) | HN1999000029A (es) |
| MY (1) | MY140504A (es) |
| NZ (1) | NZ505994A (es) |
| PA (1) | PA8469001A1 (es) |
| PE (1) | PE20000348A1 (es) |
| SV (1) | SV1999000026A (es) |
| UY (1) | UY25436A1 (es) |
| WO (1) | WO1999047138A1 (es) |
| ZA (1) | ZA992106B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| AU2005315608B2 (en) | 2004-12-15 | 2011-03-31 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors |
| JP2009514851A (ja) * | 2005-11-08 | 2009-04-09 | ランバクシー ラボラトリーズ リミテッド | （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法 |
| WO2010005389A1 (en) * | 2008-07-11 | 2010-01-14 | Forskarpatent I Syd Ab | Oxidized ldl specific antibody-fusion and conjugated proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123902A (en) * | 1995-11-02 | 2003-01-12 | Warner Lambert Co | PHARMACEUTICAL COMPOSITION FOR REGULATING LIPID CONCENTRATION CONTAINING ACYL-CoA CHOLESTEROL O-ACYLTRANSFERASE (ACAT) INHIBITOR AND AN HMG-CoA REDUCTASE INHIBITOR |
| ES2167733T3 (es) * | 1996-05-17 | 2002-05-16 | Warner Lambert Co | Inhibidores de metaloproteinasa matricial de bifenilsulfonamida. |
| CA2263886A1 (en) * | 1996-12-09 | 1998-06-18 | Warner-Lambert Company | Method for treating and preventing heart failure and ventricular dilatation |
| TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
| GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. |
-
1998
- 1998-11-20 KR KR1020007010223A patent/KR20010041916A/ko not_active Ceased
- 1998-11-20 BR BR9815745-0A patent/BR9815745A/pt not_active Application Discontinuation
- 1998-11-20 EP EP98960279A patent/EP1063991A1/en not_active Withdrawn
- 1998-11-20 AU AU15916/99A patent/AU1591699A/en not_active Abandoned
- 1998-11-20 JP JP2000536378A patent/JP2002506818A/ja active Pending
- 1998-11-20 WO PCT/US1998/024681 patent/WO1999047138A1/en not_active Ceased
- 1998-11-20 NZ NZ505994A patent/NZ505994A/xx unknown
- 1998-11-20 CA CA002309588A patent/CA2309588A1/en not_active Abandoned
-
1999
- 1999-02-24 AR ARP990100751A patent/AR018113A1/es unknown
- 1999-03-15 MY MYPI99000951A patent/MY140504A/en unknown
- 1999-03-16 CO CO99016109A patent/CO5070670A1/es unknown
- 1999-03-16 SV SV1999000026A patent/SV1999000026A/es not_active Application Discontinuation
- 1999-03-16 ZA ZA9902106A patent/ZA992106B/xx unknown
- 1999-03-16 PE PE1999000217A patent/PE20000348A1/es not_active Application Discontinuation
- 1999-03-16 HN HN1999000029A patent/HN1999000029A/es unknown
- 1999-03-16 PA PA19998469001A patent/PA8469001A1/es unknown
- 1999-03-16 GT GT199900039A patent/GT199900039A/es unknown
- 1999-03-16 UY UY25436A patent/UY25436A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999047138A1 (en) | 1999-09-23 |
| MY140504A (en) | 2009-12-31 |
| ZA992106B (en) | 1999-09-30 |
| UY25436A1 (es) | 2001-10-25 |
| CO5070670A1 (es) | 2001-08-28 |
| KR20010041916A (ko) | 2001-05-25 |
| EP1063991A1 (en) | 2001-01-03 |
| PE20000348A1 (es) | 2000-05-22 |
| GT199900039A (es) | 2000-09-06 |
| PA8469001A1 (es) | 2002-09-17 |
| AR018113A1 (es) | 2001-10-31 |
| NZ505994A (en) | 2003-10-31 |
| JP2002506818A (ja) | 2002-03-05 |
| BR9815745A (pt) | 2000-11-14 |
| SV1999000026A (es) | 2000-01-18 |
| AU1591699A (en) | 1999-10-11 |
| CA2309588A1 (en) | 1999-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032403A1 (es) | Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares | |
| ECSP074704A (es) | Combinaciones de inhibidor(es) de la absorción de esterol con modificador(es) sanguíneos para tratar cuadros vasculares | |
| MXPA03006855A (es) | Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion. | |
| ES2188285T3 (es) | Combinaciones de inhibidores del transporte de acidos biliares ileales y derivados de acido nicotinico para indicaciones cardiovasculares. | |
| ES2176755T3 (es) | Derivados anticonvulsivos utiles para el tratamiento de la esclerosis lateral amiotrofica. | |
| MX9700237A (es) | Combinaciones inhibidoras de proteasa retroviral. | |
| UY25268A1 (es) | Inhibicion de la oxidacion de lipoproteinas | |
| AP2003002743A0 (en) | Therapeutic combination of a cept inhibitor and atorvastatin | |
| UY25299A1 (es) | Combinaciones de estatina-eter carboxialquílico | |
| CL2004000366A1 (es) | USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA. | |
| PA8452701A1 (es) | Agonistas de prostaglandinas | |
| PT1140181E (pt) | Terapia de combinacao de radiacao e um inibidor de cox-2 para o tratamento da neoplasia | |
| HN1999000029A (es) | Combinaciones de estatina-inhibidor de mmp. | |
| NZ503962A (en) | ACE inhibitor (angiotensin converting enzyme) and MMP (matrix metalloproteinase inhibitor) combinations for treating fibrosis | |
| GT199800177A (es) | Combinacion eficaz para el tratamiento de la impotencia . | |
| ECSP088117A (es) | Agente desinfectante | |
| BR0312845A (pt) | Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas | |
| AU2003296807A1 (en) | Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide | |
| BR9713522A (pt) | Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos. | |
| BR0213181A (pt) | Combinações de inibidor de cox-2 | |
| ATE333279T1 (de) | Kombinationstherapie zur modulation der humanen sexualreaktion | |
| TR200100901T2 (tr) | Kateter-bazında revaskülarizasyonu önleme veya geciktirme yöntemi | |
| DE60021350D1 (de) | Mmp-hemmer bei bindegewebserweichung | |
| GT199900037A (es) | Nuevas composiciones herbicidas. | |
| ES2192703T3 (es) | Compuestos heterociclicos de guanidinilamino utiles como agonistas alfa-2 adrenoceptores. |